Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII · 70 lines · as of Apr 30, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Fidelity Advisor Biotechnology Fund |
|---|---|
| AbbVie Inc | 14.83 % |
| Alnylam Pharmaceuticals Inc | 5.52 % |
| Gilead Sciences Inc | 5.42 % |
| Insmed Inc | 3.51 % |
| Cogent Biosciences Inc | 3.45 % |
| Dianthus Therapeutics Inc | 3.37 % |
| Spyre Therapeutics Inc | 3.33 % |
| Ascendis Pharma A/S | 3.24 % |
| Argenx SE | 3.17 % |
| Biogen Inc | 2.92 % |
| Oruka Therapeutics Inc | 2.65 % |
| Amgen Inc | 2.46 % |
| Vaxcyte Inc | 2.30 % |
| Revolution Medicines Inc | 2.27 % |
| Nuvalent Inc | 2.17 % |
| Amylyx Pharmaceuticals Inc | 2.05 % |
| Apogee Therapeutics Inc | 1.97 % |
| Moderna Inc | 1.55 % |
| Xenon Pharmaceuticals Inc | 1.34 % |
| Viridian Therapeutics Inc | 1.26 % |
| Kiniksa Pharmaceuticals International Plc | 1.18 % |
| Roivant Sciences Ltd | 1.16 % |
| JADE BIOSCIENCES INC | 1.15 % |
| Praxis Precision Medicines Inc | 1.14 % |
| Crinetics Pharmaceuticals Inc | 1.11 % |
| Cytokinetics Inc | 1.05 % |
| Structure Therapeutics Inc | 1.05 % |
| Kymera Therapeutics Inc | 0.99 % |
| Natera Inc | 0.97 % |
| UCB SA | 0.93 % |
1 funds, 70 lines read.